|
BPL Medical Technologies managing director, Dr Shravan Subramanyam noted that inking India-UK FTA to propel growth prospects.
"The signing of the India–UK Free Trade Agreement, eliminating tariffs for nearly 99% of Indian medical device exports, marks a transformative step for India’s medical technology sector. This policy will accelerate our growth in key markets like the UK by boosting competitiveness and reducing costs, stated Dr Subramanyam.
Our comprehensive product portfolio at BPL Medical Technologies along with our ISO-certified factories in Bengaluru and Palakkad allow us to stay ahead and aligned with the Make in India vision to deliver advanced, affordable solutions for global healthcare needs, he added.
In FY24, India exported over Rs. 1,015 crore worth of medical devices to the UK which is a 13.11% annual increase. With this agreement, we are poised for even greater expansion, helping balance trade and integrating more deeply into global value chains, said Dr Subramanyam.
BPL Medical Technologies remain committed to providing world-class solutions and fostering sustained growth for the global healthcare and MedTech sector, he noted.
It is also reported that according to the Global Trade Research Institute, “In 2025, bilateral trade hit $54.9 billion, with India running an $11.7 billion surplus. The UK is India’s second-largest IT and business services market after the US. India exported $14.5 billion worth of goods and $18.4 billion worth of services, while importing $8.6 billion in goods and $12.6 billion in services from the UK.
Further the Global Trade Research Institute also stated India’s key exports to the UK include pharmaceuticals, smartphones, aviation fuel turbo-jets, silver bars, rice, diamonds, and textiles.
|